Physician profile
Veronica Vu
NPI 1942493762
$3,487.28
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,272 · 2022: $2,102 · 2023: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,016.15 | 2021-2022 | |
| Inspire Medical Systems, INC. | $945.55 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $374.07 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $241.02 | 2021-2023 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $176.96 | 2021-2022 | |
| Glaxosmithkline, LLC. | $160.20 | 2021-2022 | |
| Amgen INC. | $125.79 | 2022 | |
| Genentech USA, INC. | $85.12 | 2021-2022 | |
| Grifols USA, LLC | $52.11 | 2022 | |
| Genzyme Corporation | $49.85 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.61 | 2022 | |
| Mylan Specialty L.P. | $37.55 | 2021-2022 | |
| Electromed, INC. | $36.53 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $31.13 | 2021 | |
| Apria Healthcare LLC | $20.57 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $18.24 | 2022 | |
| United Therapeutics Corporation | $15.89 | 2021 | |
| Baxter Healthcare | $15.07 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.51 | 2022 | |
| Merck Sharp & Dohme LLC | $12.56 | 2021 | |
| Janssen Pharmaceuticals, INC | $10.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.